PGNY

PGNY

USD

Progyny Inc. Common Stock

$18.590+0.310 (1.696%)

Echtzeitkurs

Healthcare
Healthcare Plans
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$18.280

Hoch

$18.840

Tief

$18.030

Volumen

0.61M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.6B

Branche

Healthcare Plans

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.31M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $13.39Aktuell $18.590Hoch $26.76

KI-Analysebericht

Zuletzt aktualisiert: 3. Nov. 2025
KI-generiertDatenquelle: Yahoo Finance, Bloomberg, SEC

PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders

What's Happening With Progyny Right Now

Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash

Ähnliche Nachrichten

GlobeNewswire

Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,

Mehr anzeigen
GlobeNewswire

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs

Mehr anzeigen
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
BusinessWire

Transcarent Experience Store Expansion: More Options for Women's Health

Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the

Mehr anzeigen
Transcarent Experience Store Expansion: More Options for Women's Health
GlobeNewswire

Progyny CEO Named World Economic Forum Champion for Women's Health

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a

Mehr anzeigen
Progyny CEO Named World Economic Forum Champion for Women's Health

KI-VorhersageBeta

KI-Empfehlung

Bullisch

Aktualisiert am: 4. Nov. 2025, 17:26

BärischNeutralBullisch

64.3% Konfidenz

Risiko & Handel

Risikostufe3/5
Mittleres Risiko
Geeignet für
Moderat
Handelsleitfaden

Einstiegspunkt

$18.21

Gewinnmitnahme

$19.66

Stop-Loss

$16.58

Schlüsselfaktoren

RSI bei 71.8 deutet auf überkaufte Bedingungen hin
PDI 12.5 liegt über MDI 4.9 mit ADX 20.3, was auf einen bullischen Trend hindeutet
Handelsvolumen ist 6.9x Durchschnitt (14,478), was auf extrem starken Kaufdruck hindeutet
MACD 0.0379 liegt über der Signallinie 0.0101, was auf einen bullischen Crossover hindeutet

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.